http://interactive.snm.org/index.cfm?PageID=277 Keep up with the government. Wed, 22 May 2013 21:43:00 GMT http://interactive.snm.org/index.cfm?PageID=12634 Thu, 16 May 2013 04:00:00 GMT http://interactive.snm.org/index.cfm?PageID=12634-PageVersionID=33292 http://interactive.snm.org/index.cfm?PageID=12633 On May 10, Mallinckrodt, the Pharmaceutical business of Covidien, released a customer letter regarding the unplanned HFR shutdown that began in November 2012. Wed, 15 May 2013 04:00:00 GMT http://interactive.snm.org/index.cfm?PageID=12633-PageVersionID=33291 http://interactive.snm.org/index.cfm?PageID=12614 On April 18, the Nuclear Regulatory Commission issued an enforcement guidance memorandum (EGM). Tue, 07 May 2013 04:00:00 GMT http://interactive.snm.org/index.cfm?PageID=12614-PageVersionID=33233 http://interactive.snm.org/index.cfm?PageID=12604 NRC recently issued as RIS related to Molybdenum-99. Fri, 03 May 2013 04:00:00 GMT http://interactive.snm.org/index.cfm?PageID=12604-PageVersionID=33179 http://interactive.snm.org/index.cfm?PageID=12574 CMS is currently considering coverage for amyloid PET imaging. The following is a letter to CMS signed by experts in Alzheimer’s disease and neuroimaging, many of whom had the opportunity to testify at the January 2013 MEDCAC meeting. Fri, 19 Apr 2013 04:00:00 GMT http://interactive.snm.org/index.cfm?PageID=12574-PageVersionID=33095 http://interactive.snm.org/index.cfm?PageID=12564 NRG, the operator of the High Flux Reactor (HFR), recently provided an update concerning the necessary repairs that are currently affecting the reactor. Tue, 16 Apr 2013 04:00:00 GMT http://interactive.snm.org/index.cfm?PageID=12564-PageVersionID=33067 http://interactive.snm.org/index.cfm?PageID=12529 The Nuclear Research and consultancy Group (NRG) has issued a customer letter on the status of the HFR reactor in the Netherlands. Wed, 03 Apr 2013 04:00:00 GMT http://interactive.snm.org/index.cfm?PageID=12529-PageVersionID=32938 http://interactive.snm.org/index.cfm?PageID=12525 The April 2013 SNMMI-ACNM Health Policy and Regulatory Affairs (HPRA) Newsletter is now available. Featured in this issue, among other topics: *SNMMI prepares important comments for CMS *Update:Mallinckrodt customer letter on the supply of Mo-99 *SNMMI applauds FDA approval of Tc99m Tilmanocept(Lymphoseek) *CARE Act reintroduced Tue, 02 Apr 2013 04:00:00 GMT http://interactive.snm.org/index.cfm?PageID=12525-PageVersionID=32932 http://interactive.snm.org/rss/index.rss SNMMI has multiple feeds - click above to view the list of other feeds you may want to subscribe to. Wed, 22 May 2013 04:00:00 GMT http://interactive.snm.org/rss/index.rss-1